EASL Studio Summer Replays - EASL-The Home of Hepatology.

<img class="easl-page-header-bg-img" alt="" src="https://easl.eu/wp-content/uploads/2021/10/EASL-STUDIO-WEBPAGE-BANNER-2000x220-visual-only.png"/>

This summer, watch a selection of EASL Studio episodes, from the International Liver Congress and Season 2 on replay.

Discover the programme below and tune in on Wednesdays, 18:00 CET.

Programme

From Season 2

Wednesday 3 August, 18:00 CET	Betablockers in cirrhosis: has Baveno consensus gone too far? Prof. Aleksander Krag (Moderator), Prof. Thomas Reiberger (Faculty), Prof. Dominique Thabut (Faculty) The Baveno Consensus started over 30 years ago with the aim of reviewing current diagnostic and therapeutic strategies and producing updated definitions.But, with the extension of indication of non-steroidal beta blockers, has the consensus gone too far? Is there enough evidence for their use in already decompensated patients? How safe are they in this patient population? What do we know about the effects on refractory ascites? Circulatory dysfunction? Add to your calendar
Wednesday 10 August, 18:00 CET	New era for science dissemination: the role of social media Prof. Jesús Bañales (Moderator), Dr Ahmed Elsharkawy (Faculty), Dr Elliot B. Tapper (Faculty), Dr Juan Turnes (Faculty) In recent years social media has become a powerful tool, not only for science dissemination, but also for discussing data and networking. What is the impact of dissemination via social media? How is social media changing the way data is communicated? Should social media activity be considered a professional endeavour? Add to your calendar
Wednesday 17 August, 18:00 CET	Fats or carbs, who is the real villain? Prof. Shira Zelber-Sagi (Moderator), Prof. Bernadette Moore (Faculty), Dr Yftach Gepner (Faculty) Obesity is a global health problem that is quickly becoming the leading cause of fatty liver disease. In honour of World Obesity Day (4 March), and to address this growing public health issue, this week we will be taking a closer look at diets. What is the role of fats and carbohydrates on liver fat content? What are the current dietary recommendations? What are randomised controlled trials showing us about polyunsaturated (PUFA) and saturated fat (SFA) (e.g. palm oil)? Add to your calendar
Wednesday 24 August, 18:00 CET	Should anticoagulants be given to patients with cirrhosis to improve outcome? Prof. Pierre-Emmanuel Rautou (Moderator), Prof. Erica Villa (Faculty), Prof. Patrick Northup (Faculty) EASL Clinical Practice Guidelines on prevention and management of bleeding and thrombosis in patients with cirrhosis were recently released. Join the faculty as they discuss: What effects do anticoagulants have on survival and liver related events in cirrhosis? What are the mechanisms of action? What type of anticoagulants should be used in patients with cirrhosis? Add to your calendar
Wednesday 31 August, 18:00 CET	EASL Haemochromatosis Guidelines 2022 Prof. Heinz Zoller (Moderator), Prof. Elena Corradini (Faculty), Dr John Ryan (Faculty) Add to your calendar